Showing results (611-620 of 695) with videos related to
Sort By:
Pageof 70
Antiviral Research|March 1, 1996
The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after bindingK De Vreese, D Reymen, P Griffin, et al.Plastic and Reconstructive Surgery|August 16, 2021
Management of Calcified Cephalohematoma of Infancy: The University of Michigan 25-Year ExperienceRaquel M Ulma, Gina Sacks, Bridger M Rodoni, et al.International Journal of Pharmaceutics|September 16, 1999
Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPAJ Van Gelder, M Witvrouw, C Pannecouque, et al.Proceedings of the National Academy of Sciences of the United States of America|January 6, 2025
High organofluorine concentrations in municipal wastewater affect downstream drinking water supplies for millions of AmericansBridger J Ruyle, Emily H Pennoyer, Simon Vojta, et al.Bioconjugate Chemistry|September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imagingD S Edwards, S Liu, M C Ziegler, et al.Stroke|December 18, 2025
Trametinib Decreased Intracerebral Hemorrhages and Endothelial-to-Mesenchymal Transition in KRAS<sup>G12V</sup>-Induced Brain Arteriovenous Malformations in MiceOhnmar Myint, Bridger Freeman, Jae Yeong Jeong, et al.Health Communication|December 4, 2014
Designing for dissemination: lessons in message design from "1-2-3 pap"Elisia L Cohen, Katharine J Head, Margaret J McGladrey, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 1, 2014
Diverticular disease in Scotland: 2000-2010H M Paterson, I D Arnott, R J Nicholls, et al.Molecular Pharmacology|January 12, 1999
Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptorJ A Esté, C Cabrera, E De Clercq, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugatesM E Ultee, G J Bridger, M J Abrams, et al.Pageof 70